Literature DB >> 26340614

A Sex-Stratified Multivariate Risk Factor Model for Anterior Cruciate Ligament Injury.

Bruce D Beynnon1, Daniel R Sturnick2, Erin C Argentieri1, James R Slauterbeck1, Timothy W Tourville1, Sandra J Shultz3, Pamela M Vacek4.   

Abstract

Entities:  

Year:  2015        PMID： 26340614      PMCID： PMC4641547          DOI： 10.4085/1062-6050-50.10.05

Source DB:  PubMed          Journal:  J Athl Train        ISSN： 1062-6050            Impact factor:   2.860


× No keyword cloud information.
  24 in total

1.  New method to identify athletes at high risk of ACL injury using clinic-based measurements and freeware computer analysis.

Authors:  Gregory D Myer; Kevin R Ford; Timothy E Hewett
Journal:  Br J Sports Med       Date:  2010-11-16       Impact factor: 13.800

2.  Cartilage injury after acute, isolated anterior cruciate ligament tear: immediate and longitudinal effect with clinical/MRI follow-up.

Authors:  Hollis G Potter; Sapna K Jain; Yan Ma; Brandon R Black; Sebastian Fung; Stephen Lyman
Journal:  Am J Sports Med       Date:  2011-09-27       Impact factor: 6.202

3.  Application of a clinic-based algorithm as a tool to identify female athletes at risk for anterior cruciate ligament injury: a prospective cohort study with a nested, matched case-control analysis.

Authors:  John Goetschius; Helen C Smith; Pamela M Vacek; Leigh Ann Holterman; Sandra J Shultz; Timothy W Tourville; James Slauterbeck; Robert J Johnson; Bruce D Beynnon
Journal:  Am J Sports Med       Date:  2012-08-09       Impact factor: 6.202

4.  Relationship between markers of type II collagen metabolism and tibiofemoral joint space width changes after ACL injury and reconstruction.

Authors:  Timothy W Tourville; Robert J Johnson; James R Slauterbeck; Shelly Naud; Bruce D Beynnon
Journal:  Am J Sports Med       Date:  2013-02-19       Impact factor: 6.202

5.  Development and validation of a clinic-based prediction tool to identify female athletes at high risk for anterior cruciate ligament injury.

Authors:  Gregory D Myer; Kevin R Ford; Jane Khoury; Paul Succop; Timothy E Hewett
Journal:  Am J Sports Med       Date:  2010-07-01       Impact factor: 6.202

6.  A prospective evaluation of the Landing Error Scoring System (LESS) as a screening tool for anterior cruciate ligament injury risk.

Authors:  Helen C Smith; Robert J Johnson; Sandra J Shultz; Timothy Tourville; Leigh Ann Holterman; James Slauterbeck; Pamela M Vacek; Bruce D Beynnon
Journal:  Am J Sports Med       Date:  2011-11-23       Impact factor: 6.202

7.  Progressive chondrocyte death after impact injury indicates a need for chondroprotective therapy.

Authors:  Michal Szczodry; Christian H Coyle; Scott J Kramer; Patrick Smolinski; Constance R Chu
Journal:  Am J Sports Med       Date:  2009-10-28       Impact factor: 6.202

8.  Assessment of early tibiofemoral joint space width changes after anterior cruciate ligament injury and reconstruction: a matched case-control study.

Authors:  Timothy W Tourville; Robert J Johnson; James R Slauterbeck; Shelly Naud; Bruce D Beynnon
Journal:  Am J Sports Med       Date:  2013-03-04       Impact factor: 6.202

9.  The effects of generalized joint laxity on risk of anterior cruciate ligament injury in young female athletes.

Authors:  Gregory D Myer; Kevin R Ford; Mark V Paterno; Todd G Nick; Timothy E Hewett
Journal:  Am J Sports Med       Date:  2008-03-07       Impact factor: 6.202

10.  Geographic mapping of meniscus and cartilage lesions associated with anterior cruciate ligament injuries.

Authors:  James R Slauterbeck; Petteri Kousa; Blake C Clifton; Shelly Naud; Timothy W Tourville; Robert J Johnson; Bruce D Beynnon
Journal:  J Bone Joint Surg Am       Date:  2009-09       Impact factor: 5.284
View more
  1 in total

1.  ACL Research Retreat VII: An Update on Anterior Cruciate Ligament Injury Risk Factor Identification, Screening, and Prevention.

Authors:  Sandra J Shultz; Randy J Schmitz; Anne Benjaminse; Malcolm Collins; Kevin Ford; Anthony S Kulas
Journal:  J Athl Train       Date:  2015-09-04       Impact factor: 2.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.